West Pharmaceutical Services, Inc. WST
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 214.00M | 154.00M | 138.80M | 132.10M | 140.00M |
| Total Depreciation and Amortization | 45.90M | 46.20M | 45.20M | 47.00M | 43.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -51.10M | 9.80M | 8.80M | -9.70M | 12.10M |
| Change in Net Operating Assets | -19.30M | -86.00M | -102.90M | 81.70M | 2.10M |
| Cash from Operations | 189.50M | 124.00M | 89.90M | 251.10M | 197.20M |
| Capital Expenditure | -39.10M | -43.20M | -42.70M | -76.10M | -63.30M |
| Sale of Property, Plant, and Equipment | 126.90M | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -8.90M | -- | -- | -- | -- |
| Cash from Investing | 78.90M | -43.20M | -42.70M | -76.10M | -63.30M |
| Total Debt Issued | 0.00 | 50.00M | -- | -- | -- |
| Total Debt Repaid | -500.00K | -50.40M | -300.00K | -300.00K | -300.00K |
| Issuance of Common Stock | 6.50M | 8.80M | 7.50M | 4.60M | 4.00M |
| Repurchase of Common Stock | -232.30M | -156.70M | -300.10M | -200.00K | -100.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -15.50M | -15.70M | -15.80M | -15.80M | -15.10M |
| Other Financing Activities | 0.00 | -800.00K | -- | 0.00 | 0.00 |
| Cash from Financing | -241.80M | -164.80M | -308.70M | -11.70M | -11.50M |
| Foreign Exchange rate Adjustments | 1.70M | -1.60M | -8.40M | -500.00K | -3.60M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 28.30M | -85.60M | -269.90M | 162.80M | 118.80M |